Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Callisto Pharmaceuticals
Callisto Pharmaceuticals officials describe recent developments
February 14th, 2007
Callisto Pharmaceuticals officials describe recent developments. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Callisto Pharmaceuticals. Report 1: Callisto Pharmaceuticals, Inc. (KAL; CA4) announced that Dr. Geoffrey Henson has become a consultant to the company. Henson has extensive experience in early stage clinical development of oncology drugs. "I am very pleased to have Geoff as a consultant to Callisto as the company embarks on the next phase of its evolution," said Gary Jacob, Callisto chief executive officer. "The company will benefit immediately...
Source: Medical Patent Law Weekly (2007-02-14)
|
